Abstract C20: Phase I study of ombrabulin, a vascular disrupting agent (VDA), administered every 3 weeks to Japanese patients with advanced solid tumors.

2011 ◽  
Author(s):  
Takayasu Kurata ◽  
Haruyasu Murakami ◽  
Yasuhito Fujisaka ◽  
Hidemi Kiyota ◽  
Kazuhiko Nakagawa ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors

2011 ◽  
Vol 68 (4) ◽  
pp. 959-970 ◽  
Author(s):  
Alejandro D. Ricart ◽  
Edward A. Ashton ◽  
Matthew M. Cooney ◽  
John Sarantopoulos ◽  
Joanna M. Brell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

scholarly journals Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors

2016 ◽  
Vol 48 (1) ◽  
pp. 28-36 ◽  
Author(s):  
Do-Youn Oh ◽  
Tae-Min Kim ◽  
Sae-Won Han ◽  
Dong-Yeop Shin ◽  
Yun Gyoo Lee ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

A phase I study of resminostat in Japanese patients with advanced solid tumors

2015 ◽  
Vol 75 (6) ◽  
pp. 1155-1161 ◽  
Author(s):  
Satoru Kitazono ◽  
Yutaka Fujiwara ◽  
Shinji Nakamichi ◽  
Hidenori Mizugaki ◽  
Hiroshi Nokihara ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

2013 ◽  
Vol 19 (17) ◽  
pp. 4832-4842 ◽  
Author(s):  
Cristiana Sessa ◽  
Patricia Lorusso ◽  
Anthony Tolcher ◽  
Françoise Farace ◽  
Nathalie Lassau ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

Abstract A167: A phase I study of single-agent BEZ235 (SDS sachet), once- or twice-daily, in Japanese patients with advanced solid tumors.

2013 ◽  
Author(s):  
Koichiro Watanabe ◽  
Hironobu Minami ◽  
Satoshi Otsu ◽  
Yoshinori Hirashima ◽  
Ryotaro Morinaga ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors

2017 ◽  
Vol 109 (1) ◽  
pp. 193-198 ◽  
Author(s):  
Toshihiko Doi ◽  
Becker Hewes ◽  
Tomoyuki Kakizume ◽  
Takeshi Tajima ◽  
Norifumi Ishikawa ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors
Sign in / Sign up

Export Citation Format

Share Document